Irisin: Unveiling the Molecular Messenger of Exercise-Induced Metabolic Transformation

Molecular Origin and Biosynthesis

Irisin is produced as a part of a large protein FNDC5 (Fibronectin Type III Domain-Containing Protein 5), which is cleaved off during physical exercise especially intense or long-lasting, to form an active fragment of the protein, called irisin, which then is secreted into the bloodstream. Key characteristics of FNDC5/irisin production are its release during muscular contraction, physical exercise-dependent, especially of intense and long-lasting kind, influenced by various metabolic and hormonal parameters, and the irisin is able to cross the blood-brain barrier. Because of its newly found functions as a molecular messenger, which communicates between muscles and body’s metabolic tissues during physical exercise, in order to stimulate improvements of health and physical condition, precise and quantitative measurements of FNDC5/irisin in biological samples are crucial and a high-quality irisin ELISA kit is often used for these aims in research and in clinics.

Cellular Mechanisms of Action

Irisin exerts its molecular functions primarily by activating brown adipose tissue and other cellular systems involved in energy-expenditure and glucose-metabolism. It thereby stimulates browning of white adipose-tissue, i.e. a reprogramming of white adipocytes to increase their energy-expenditure similar to that of brown adipocytes, which are highly metabolically active and therefore involved in increased calorie-expenditure and improved insulin-sensitivity. The effects of irisin on browning of white adipose-tissue as well as on various other cellular systems involved in energy-expenditure and glucose-metabolism represent key aspects of the molecular functions of irisin.

Brown Adipose Tissue Browning

When FNDC5 is cleaved by proteolytic processing, irisin is released. This hormone has numerous biological functions at the molecular level, e.g. it can stimulate the so called browning of white fat tissue, which is storing energy in the form of fat in the form of white adipocytes (white fat cells). White adipocytes are storing energy in contrast to brown fat cells a lot of energy in the form of fat. Irisin can trigger a process called browning. This process changes the characteristic of white fat cells in active metabolically brown fat cells. The metabolism of brown fat cells leads to an increase of the metabolism, thus more energy is burned, which leads to an increase of the expenditure of energy. The calories, which are consumed with the food, are thereby used more efficiently and it is also possible to consume the same amount of calories with a lower weight, because the energy from the fat in the white fat cells is released. In addition, the metabolism of brown fat cells improves the insulin sensitivity. Therefore, browning of white fat cells can prevent and treat obesity and type 2 diabetes. Furthermore, browning of white fat cells can increase the metabolic rate, which leads to a higher temperature production in the body, which can be especially useful in cold situations. The browning of white fat cells by irisin is a new mechanism of action of physical exercise, which is well known to increase the activity of brown fat cells and to improve the insulin sensitivity and to prevent and treat obesity and type 2 diabetes. In summary, the browning of white adipocytes by irisin is a new mechanism of physical exercise and it is a very promising approach for the prevention and treatment of metabolic diseases like obesity and type 2 diabetes.

Broader Health Implications

In addition to its function in metabolism irisin exerts effects of a neurological protective nature, is involved in the preservation of cognitive functions, potentially can counteract neurodegenerative diseases and above all support brain health and enhance neuroplasticity. Its influence on improving insulin sensitivity and glucose metabolism potentially can be used for the prevention and treatment of type 2 diabetes and for interventions aimed at reducing obesity. Finally, the effects irisin exerts on cardiovascular health include potential anti-inflammatory effects, enhanced endothelial function, an increased resilience of the cardiovascular system, and an effect on lipid metabolism.

Emerging Research and Future Perspectives

Irisin is also the focus of current scientific research. Physiological pathways of action and individual differences in effects as well as well as new therapeutic approaches and the aging-related decrease in metabolic fitness are of particular interest to scientists. It is especially interesting for researchers whether it is possible to improve the metabolic fitness of sedentary individuals by mimicking the molecular processes that occur during physical exercise. For all these purposes, a precise quantitative analysis of irisin by high-quality ELISA kits is required.

Conclusion

Irisin, as an exercise-induced hormone, links physical exercise and metabolic health. In particular, irisin, a recently identified and newly characterized protein released from FNDC5 by proteolytic processing, is a molecular messenger for muscle-to-bat-issue communication, i.e. it conveys signals from muscle to adipose-tissue (and other) organs. To understand irisin-induced metabolic changes in health and disease, i.e. in obesity and type 2 diabetes, as well as to design and test putative irisin-related applications for treatment and prevention of these diseases, in depth analysis of irisin production, cellular and physiological actions as well as its possible application as a novel biomarker will be required. Thus, there is a need for high quality irisin ELISA kits to determine amounts of irisin in bio samples of interest. These bio samples include blood and urine from obese subjects and from subjects with type 2 diabetes as well as bio samples from models of human obesity and type 2 diabetes, e.g. mouse models of human obesity and type 2 diabetes. Research to determine irisin’s potential to be used as a drug, as well as studies designed to test putative irisin-related applications, in addition to studies required to determine irisin’s effects on metabolism in health and disease, i.e. effects on metabolism of obese subjects and on metabolism of subjects with type 2 diabetes, as well as the effects of irisin on metabolic processes in models of human obesity and type 2 diabetes, require and will benefit from high quality quantitative methods to measure amounts of this protein in bio samples of interest. With irisin having the potential to be used as a novel molecular-target for treatment of human obesity and type 2 diabetes, the amounts of this protein in bio samples will also be useful as a biomarker to monitor the effects of physical exercise as well as the effects of putative irisin-related applications, in health and disease. The bioactive properties of irisin and its effects on energy expenditure by means of browning of white adipose-tissue, on insulin-sensitivity and on mitochondrial biogenesis, function and dynamics as well as on neurological functions, thus support the notion that the use of irisin as a novel drug for treatment of human obesity and type 2 diabetes is a highly promising area of future research with novel therapeutic potential. Thus, there is a strong need for in depth research using high quality quantitative methods for determination of amounts of this bioactive peptide in bio samples of interest, in order to fully explore its bioactive properties and its possible applications.